Endogenous Manic-Paraphrenic States
https://doi.org/10.30629/2618-6667-2021-19-1-90-101
Abstract
Purpose of the work: analysis of changes in the views of domestic and foreign researchers on the clinical and biological features of manic-paraphrenic states developing within the framework of endogenous paroxysmal states psychoses.
Material and method: by the keywords “mania, paraphrenia, manic, paraphrenic”, “manic-paraphrenic state”, publications available to authors were selected in the databases MEDLINE/PubMed, Scopus, Webofscience, eLibrary.
Conclusion: the following areas of research have been identified: 1) the prevalence of manic-paraphrenic states at the present time; 2) evolution of researchers’ opinions regarding these psychoses throughout the entire period of the study of the issue; 3) a modern point of view on the nosology of manic-paraphrenic states and their place in current classifications of mental disorders; 4) topical issues of the pathogenesis of such disorders.
About the Authors
S. V. Sizov
FSBSI “Mental Health Research Centre”
Russian Federation
Russian Federation
Department of Endogenous Mental Disorders and Affective Conditions
Moscow
I. V. Oleichik
FSBSI “Mental Health Research Centre”
Russian Federation
Russian Federation
MD, PhD, Dr. of Sci. (Med.), Principal Researcher, Department of Endogenous Mental Disorders and Affective Conditions, Mental Health Research Centre
Moscow
P. A. Baranov
FSBSI “Mental Health Research Centre”
Russian Federation
Russian Federation
MD, PhD, Cand. of Sci. (Med.), Researcher, Department for the Study of Endogenous Mental Disorders and Affective Conditions
Moscow
References
1. Tochilov VA. O trudnostiakh v diagnostike i lechenii atipichnykh affektivnykh psikhozov. Obozrenie psikhiatrii i meditsinskoi psikhologii imeni V.M. Bekhtereva. 1992;4:28–36. (In Russ.).
2. Pashkovskii VE. Klinicheskie osobennosti breda messianstva pri psikhicheskikh rasstroistvakh shizofrenicheskogo spektra. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2006;106(4):15–20. (In Russ.).
3. Subbotskaya NV. Psychopathology of acute paraphrenic syndrome and its typological variants. Psychiatry. 2005;5:26–31. (In Russ.).
4. Sokolov AV. Psychopathological features and delusion of exaggerated self-esteem in endogenous manic-delusion states. Zhurnal nevrologii i psixiatrii imeni S.S. Korsakova. 2012;112(2):18–24. (In Russ.).
5. Shumskij NG. K klinike parafrennoj (fantasticheski-paranoidnoj) shizofrenii. Zhurnal nevropatologii i psixiatrii imeni S.S. Korsakova. 1958;58(4):462–470. (In Russ.).
6. Tiganov AS. Concerning of the features of maniac states occurring in schizophrenia of the shiftlike form. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova. 1969;69(2):249–253. (In Russ.).
7. Sokolova BV. The clinical picture and psychopathology of acute paraphrenic states in schizophreniа. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova. 1968;5:754–758. (In Russ.).
8. Snezhnevskii AV. Klinicheskaia psikhopatologiia. Rukovodstvo po psikhiatrii. Pod red. A.V. Snezhnevskogo. M., 1983;T.1:16–80. (In Russ.).
9. Appelbaum P, Clark Robbins P, Roth Loren H. Dimensional Approach to Delusions: Comparison Across Types and Diagnoses. The American Journal of psychiatry. 1999;156:1938–1943. DOI: 10.1176/ajp.156.12.1938
10. Casanova M. The Pathology of Paraphrenia. Current Psychiatry Reports. 2010;12:196–201. DOI: 10.1007/s11920-010-0108-8
11. Brodaty H, Sachdev P, Koschera A, Monk D, Cullen B. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. Br. J. Psychiatry. 2003;183:213–219. DOI: 10.1192/bjp.183.3.213. PMID: 12948993
12. Girard C. Clinical characterization of late- and very late-onset first psychotic episode in psychiatric inpatients. The American Journal of Geriatric Psychiatry. 2008:16(6):478–487. DOI: 10.1097/JGP.0b013e31816c7b3c
13. Howard R, Rabins P. Late paraphrenia revisited. Br. J. Psychiatry. 1997;171:406–408. DOI: 10.1192/bjp.171.5.406. PMID: 9463595
14. Reeves RR, Brister JC. Psychosis in late life: emerging issues. J. Psychosoc. Nurs. Ment. Health Serv. 2008;46(11):45–52. DOI: 10.3928/02793695-20081101-09. PMID: 19051578
15. Yamada M. Senile Dementia of the Neurofibrillary Tangle Type (SD-NFT). Brain Nerve. 2018;5(70):533–541. DOI: 10.11477/mf.1416201035
16. Conus P, Cotton S, Bechdolf A, Nelson B, Chenen A. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. Journal of Affective Disorder. 2010;1(127):316–320. DOI: 10.1016/j.jad.2010.06.016
17. Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord. 2008;10(1Pt.2):215–230. DOI: 10.1111/j.1399-5618.2007.00564.x PMID: 18199238
18. van Os, J, Kapur S. Schizophrenia. Lancet. 2009;22(374):635–645. DOI: 10.1016/S0140-6736(09)60995-8
19. Roy M, Neale M, Kendler K. The Genetic Epidemiology of Self-Esteem. Br. J. Psychiatry. 1995;166(6):813–820. DOI: 10.1192/bjp.166.6.813
20. Torrent C, Martínez-Arán A, Amann B, Daban C, Tabarés-Seisdedos R, González-Pinto A. Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects. Acta Psychiatr. Scand. 2007;6(116):453–460. DOI: 10.1111/j.1600-0447.2007.01072.x
21. Bech P, BolwigТ, Kramp P, Rafaelsen O. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Psychiatr. Pol. 2011;45(1):61–78.
22. Świtaj P, Grygiel P, Chrostek A, Wciórka J. Investigating the Roles of Loneliness and Clinician- And Self-Rated Depressive Symptoms in Predicting the Subjective Quality of Life Among People With Psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 2018;53(2):183–193. DOI: 10.1007/s00127-017-1470-1
23. Bentall R, Rowse G, Shryane N. The cognitive and affective structure of paranoid delusions. A transdiagnostic investigation of patients with schizophrenia spectrum disorders and depression. Arch. Gen. Psychiatry. 2009;66:236–247. DOI: 10.1001/archgenpsychiatry.2009.1
24. Beck AT, Rector NA. Cognitive approaches to schizophrenia: theory and therapy. Annu. Rev. Clin. Psychol. 2005;1:577–606. DOI: 10.1146/annurev.clinpsy.1.102803.144205 PMID: 17716100
25. Horowitz MJ. A cognitive model of hallucinations. Am. J. Psychiatry. 1975;132(8):789–795. DOI: 10.1176/ajp.132.8.789. PMID: 1147062
26. Freeman D, Garety P. Advances in understanding and treating persecutory delusions: a review. Soc. Psychiatry Psychiatr Epidemiol. 2014;49:1179–1189. DOI: 10.1007/s00127-014-0928-7
27. Garety P, Fowler A, Bebbington P, Freeman D. A cognitive model of the positive symptoms of psychosis. Psychol. Med. 2001;2(31):189–195. DOI: 10.1017/s0033291701003312
28. Morrison H, Welgus H, Stockley R, Birnett D. Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity. American Journal of Respiratory Cell and Molecular Biology. 1990;2:263–269.
29. Swann AC, Janicak PL, Calabrese JR, Bowden CL, Dilsaver SC, Morris DD, Petty F, Davis JM. Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J. Affect. Disord. 2001;67(1–3):123–132. DOI: 10.1016/s0165-0327(01)00447-5. PMID: 11869759
30. Krabbendam L, Myin-Germeys I, De Graaf R, Vollebergh W, Nolen WA, Iedema J, van Os J. Dimensions of depression, mania and psychosis in the general population. Psychol. Med. 2004;34(7):1177–1186. DOI: 10.1017/s0033291703001892 PMID: 15697044
31. Azorin J, Akiskal H, Hentouche E. The mood-instability hypothesis in the origin of mood-congruent versus mood-incongruent psychotic distinction in mania: validation in a French National Study of 1090 patients. J. Affect. Disord. 2006;96:215–223.
32. Berrios G. Is the concept of “dimension” applicable to psychiatric objects? World Psychiatry. 2013;1(12):76–78. DOI: 10.1002/wps.20019
33. Andreasen N. DSM and the death of phenomenology in america: an example of unintended consequences. Schizophrenia Bulletin. 2007;1(33):8–12. DOI: 10.1093/schbul/sbl054
34. Savenko IuS. Mozhno li ischerpat’ psikhopatologiiu? Nezavisimyi psikhiatricheskii zhurnal. 2016;3:29–32. (In Russ.).
35. Knowles R, McCarthy-Jones S, Rowse G. Grandiose delusions: A review and theoretical integration of cognitive and affective perspectives. Clinical Psychology Review. 2011;31(4):684–696. DOI: 10.1016/j.cpr.2011.02.009
36. Radermaker S, Sirois F. Late paraphrenia: an accidental finding. Presse Med. 2013;42(5):911–912. DOI: 10.1016/j.lpm.2012.06.018
37. Jacobowski NL, Heckers S, Bobo WV. Delirious mania: detection, diagnosis, and clinical management in the acute setting. J. Psychiatr. Pract. 2013;19(1):15–28. DOI: 10.1097/01.pra.0000426324.67322.06. PMID: 23334676
38. Morozova MA. Clinic, course and prognosis of affective psychosis, proceeding with a predominance of manic disorders. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova. 1989;89(4):82–87. (In Russ.).
39. Rifkin A, Doddi S, Karajgi B, Borenstein M, Munne R. Dosage of haloperidol for mania. Br. J. Psychiatry. 1994;165(1):113–116. DOI: 10.1192/bjp.165.1.113 PMID: 7953013
40. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. J. Affect. Disord. 2007;103(1–3):5–11. DOI: 10.1016/j.jad.2007.05.019 Epub. 2007 Jul 12. PMID: 17628692
41. Vorobyev RV. Clinical typology of mixed mania in bipolar affective disorder. Russian Psychiatric Journal. 2014;1:33–42. (In Russ.).
42. Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Schizophrenia, neuroleptic medication and mortality. Br. J. Psychiatry. 2006;188:122–127. DOI: 10.1192/bjp.188.2.122. PMID: 16449697
43. Smulevich AB. Depressii v obshchei meditsine. Rukovodstvo dlia vrachei. M.: Meditsinskoe informatsionnoe agentstvo, 2001. (In Russ.).
44. Bubnova, US, Dorofeykov VV, Maso GE, Petrova NN. To the question of the mechanisms of development of depression in schizophrenia. Psihiatriya i psihofarmakoterapiya. 2012;4(14):21–26. (In Russ.).
45. Petrova NN. Antipsychotics are the main treatment for schizophrenia and other psychoses. Fundamentalnye aspekty psihicheskogo zdorovya. 2016;3:124–134. (In Russ.).
46. Barnes T, McPhillips M. How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease- related negative symptoms in schizophrenia. International clinical psychopharmacology. 1995;10(3):115–121.
47. Karamatskos E, Mulert C, Lambert M, Naber D. Subjective well-being of patients with schizophrenia as a target of drug treatment. Curr. Pharm. Biotechnol. 2012;13(8):1490–1499. DOI: 10.2174/138920112800784862 PMID: 22283757
48. Crismon M, Argo T, Bendele S, Suppes T. Texas Medication Algorithm Project Procedural Manual: Bipolar Disorder Algorithms. The Texas Department of State Health Services. 2007:66.
49. Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflammation. 2013;10:43. DOI: 10.1186/1742-2094-10-43 PMID: 23547920; PMCID: PMC3626880
50. Klyushnik TP, Omelchenko MA, Sarmanova ZV, Zozulya SA, Otman IN, Dupin AM, Kaleda VG. Possibilities of the use of immunological indicators for the assessment of the risk of manifestation of endogenous psychoses in patients with nonpsychoticdisorders of the juvenile age. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014;114(10):97–101. (In Russ.).
51. Small J, Milstein V, Malloy F, Medlock C, Klapper M. Clinical and quantitative EEG studies of mania. J. Affect. Disord. 1999;53:217–224. DOI: 10.1016/S0165-0327(98)00124-4
52. Iznak AF, Iznak EV, Klushnik TP, Panteleeva GP, Oleichik IV, Abramova LI, Stolyarov SA. Neurophysiological and neuroimmunological indicators for predicting the effectiveness of therapy for affective-delusional conditions in the context of paroxysmal schizophrenia. Psychiatry. 2014;2:47–52. (In Russ.).
53. Brusov OS, Matveev IA, Kirillov PS, Faktor MI, Karpova NS, Vasil’eva EF, Katasonov AB, Zozulya SA, Klyushnik TP. Risk assessment of thrombotic events in patients with schizophrenia and schizoaffective disorder in the acute state: the “fibrinodynamics” technology. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;117(11):91–100. (In Russ.). DOI: 10.17116/jnevro201711711191-100
54. Meleshko TK, Kritskaya VP. Towards the problem of pecularites of schizophrenic pathology. Psychiatry. 2016;72(4):20–26. (In Russ.).
55. Iznak AF, Iznak EV, Klushnik TP, Oleichik IV, Abramova LM, Kobelkov GM, Lozhnikov MA. Regression models of the relationship of clinical and neurobiological parameters in the treatment of manic- delusional conditions in the context of paroxysmal schizophrenia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2016;116(3):33–38. (In Russ.). DOI: 10.17116/jnevro20161163133-38
56. Zozulya SA, Oleichik IV, Androsova LV, Otman IN, Sarmanova ZV, Stolyarov SA, Bizyaeva AS, Unilaynen OA, Klyushnik TP. Monitoring trand of endogenous psychoses by immunological indicators. Psihicheskoe zdorov’e. 2017;15(1):11–18. (In Russ.).
57. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: infl ammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31. DOI: 10.1016/j.it.2005.11.006 Epub 2005 Nov 28. PMID: 16316783; PMCID: PMC3392963
58. Hoir isch-Cl apauch S, Nardi AE, Gr is JC, Brenner B. Mental disorders and thrombotic risk. Semin. Thromb. Hemost. 2013;39(8):943–949. DOI: 10.1055/s-0033-1357486 Epub 2013 Oct 10. PMID: 24114008
59. Roche-Bayard P, Rossi R, Mnn J, Cordier J, Delahaye J. Left pulmonary artery thrombosis in chlorpromazineinduced lupus. Chest. 1990;98(6):1545.
60. Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet. 2000;356(9237):1219–1223. DOI: 10.1016/S0140-6736(00)02784-7. PMID: 11072939
Review
For citations:
Sizov S.V., Oleichik I.V., Baranov P.A. Endogenous Manic-Paraphrenic States. Psychiatry (Moscow) (Psikhiatriya). 2021;19(1):90-101. (In Russ.) https://doi.org/10.30629/2618-6667-2021-19-1-90-101
Views:
629
Email this article 
